SRAS-CoV-2, vaccination et traitement ambulatoire précoce: programme complet

Publié le par

Ci-dessous 4 vidéos présentant:

  • Remarques liminaires de Jean-Pierre Kiekens
  • Présentation PowerPoint par Geert Vanden Bossche, DVM, PHD
  • Présentation PowerPoint par le professeur Peter McCullough, MD, MPH
  • Discussion modérée entre les deux experts

Vous pouvez trouver les biographies des deux experts (en langue anglaise) et les principales références ci-dessous les vidéos.

Pour les vidéos, vous pouvez activer les sous-titres et leur traduction automatique.

BIOS

Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development. Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness. Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech/ Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.>>  Two Prominent Experts Discuss Urgent Recommendations to Handle the Pandemic

>>  Les véhicules électriques sont-ils une solution ? Résumé Exécutif

Peter McCullough is Professor of Medicine, Vice Chief of Internal Medicine at Baylor University Medical Center in Dallas, Texas. After receiving a bachelor’s degree from Baylor University, Dr. McCullough completed his medical degree as an Alpha Omega Alpha graduate from the University of Texas Southwestern Medical School in Dallas. He went on to complete his internal medicine residency at the University of Washington in Seattle, cardiology fellowship including service as Chief Fellow at William Beaumont Hospital, and master’s degree in public health at the University of Michigan. Dr. McCullough is a consultant cardiologist and Vice Chief of Medicine at Baylor University Medical Center in Dallas, TX. He is a Principal Faculty in internal medicine for the Texas A & M University Health Sciences Center. Dr. McCullough is an internationally recognized authority on the role of chronic kidney disease as a cardiovascular risk state with over 1000 publications and over 500 citations in the National Library of Medicine. His works include the “Interface between Renal Disease and Cardiovascular Illness” in Braunwald’s Heart Disease Textbook. Dr. McCullough is a recipient of the Simon Dack Award from the American College of Cardiology and the International Vicenza Award in Critical Care Nephrology for his scholarship and research. Dr. McCullough is a founder and current president of the Cardiorenal Society of America, an organization dedicated to bringing cardiologists and nephrologists together to work on the emerging problem of cardiorenal syndromes. His works have appeared in the New England Journal of Medicine, Journal of the American Medical Association, Lancet and other top-tier journals worldwide. He is the co-editor of Reviews in Cardiovascular Medicine, and associate editor of the American Journal of Cardiology and Cardiorenal Medicine. He serves on the editorial boards of multiple specialty journals. Dr. McCullough has made presentations on the advancement of medicine across the world and has been an invited lecturer at the New York Academy of Sciences, the National Institutes of Health, U.S. Food and Drug Administration (FDA), European Medicines Agency, and the U.S. Congressional Oversight Panel.

>>  Les véhicules électriques sont-ils une solution ? Résumé Exécutif

REFERENCES

The theoretical article he is referring to is: https://journals.plos.org/plosbiology…​ You can find many more info and references on Dr Vanden Bossche’s website: https://www.geertvandenbossche.org/

https://www.sciencedirect.com/science…​ https://pubmed.ncbi.nlm.nih.gov/33387…​ Also watch our October webinar with Prof. McCullough. https://covexit.com/outpatient-early-…